Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes

Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes

Breast cancer (BRCA) is the most frequent cancer type that afflicts women. Unfortunately, despite all the current therapeutic strategies, many patients develop chemoresistance hampering the efficacy of treatment. Hence, an early indicator of therapy efficacy might aid in the search for better treatm...

Full description

Bibliographic Details
Main Authors: Victor Manuel Ruiz-Rodríguez, Eneida Turiján-Espinoza, Jaime Arturo Guel-Pañola, Mariana Haydee García-Hernández, José de Jesús Zermeño-Nava, Nallely López-López, Sofia Bernal-Silva, Esther Layseca-Espinosa, Ezequiel M. Fuentes-Pananá, Ana María Estrada-Sánchez, Diana Patricia Portales-Pérez
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Pharmacology
Subjects:
chemoresistance
P2X7 receptor
A2A receptor
CD8+ T cells
obesity
diabetes
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.576955/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2020.576955/full

Similar Items